2009-01-13
Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer
Publication
Publication
British Journal of Cancer , Volume 100 - Issue 1 p. 13- 18
With docetaxel as effective chemotherapy for hormone refractory prostate cancer (HRPC), the number of new treatment combinations for HRPC is expanding demanding a fast-track screening system. This review elaborates on the use of xenograft models to select the most promising combination therapies for entering into phase II clinical trials.
| Additional Metadata | |
|---|---|
| , , , | |
| doi.org/10.1038/sj.bjc.6604822, hdl.handle.net/1765/27068 | |
| British Journal of Cancer | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
van Weerden, W., Bangma, C., & de Wit, R. (2009). Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer. British Journal of Cancer, 100(1), 13–18. doi:10.1038/sj.bjc.6604822 |
|